Similar to deep vein thrombosis and pulmonary embolism the question that remains unanswered is the value of screening for prothrombin G20210A with cerebral venous thrombosis in order to predict who is at high risk of recurrent venous thromboembolism? This evidence concerns the gene F2 and pulmonary embolism.